DexCom (DXCM) Reports Q4 Revenue Up 12% to $281M, Net Income Increases 18%

DexCom Inc. (DXCM) reported fourth-quarter revenue of $281 million, up 12% year-over-year, and net income of $78 million, reflecting an 18% increase. The rise followed strong sales of its continuous glucose monitoring system, driven by higher adoption in the U.S. and international markets. For the quarter ended January 31, 2026, the company generated $281 million in revenue and $78 million in net income, compared to $251 million and $66 million in the same period of 2025, respectively.